BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 211 filers reported holding BEAM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $35,327,654 | -16.4% | 1,468,748 | +10.9% | 0.00% | -20.0% |
Q2 2023 | $42,280,918 | +14.8% | 1,324,175 | +10.1% | 0.01% | 0.0% |
Q1 2023 | $36,815,324 | +81546.7% | 1,202,329 | +4.3% | 0.01% | -16.7% |
Q4 2022 | $45,091 | -99.9% | 1,152,940 | +4.4% | 0.01% | -25.0% |
Q3 2022 | $52,617,000 | +40.5% | 1,104,475 | +14.2% | 0.01% | +60.0% |
Q2 2022 | $37,441,000 | -24.2% | 967,223 | +12.2% | 0.01% | -16.7% |
Q1 2022 | $49,375,000 | -27.0% | 861,694 | +1.5% | 0.01% | -25.0% |
Q4 2021 | $67,624,000 | -5.6% | 848,589 | +3.1% | 0.01% | -20.0% |
Q3 2021 | $71,600,000 | -18.8% | 822,894 | +20.1% | 0.01% | -16.7% |
Q2 2021 | $88,201,000 | +84.8% | 685,274 | +14.9% | 0.01% | +71.4% |
Q1 2021 | $47,736,000 | +10.1% | 596,405 | +12.3% | 0.01% | 0.0% |
Q4 2020 | $43,347,000 | +295.9% | 530,965 | +19.4% | 0.01% | +250.0% |
Q3 2020 | $10,948,000 | +85.7% | 444,690 | +111.2% | 0.00% | +100.0% |
Q2 2020 | $5,894,000 | +357.6% | 210,529 | +194.2% | 0.00% | – |
Q1 2020 | $1,288,000 | – | 71,566 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |